Article Text

Download PDFPDF
Original article
Further delineation of the phenotype of chromosome 14q13 deletions: (positional) involvement of FOXG1 appears the main determinant of phenotype severity, with no evidence for a holoprosencephaly locus
  1. Gijs W E Santen1,
  2. Yu Sun1,
  3. Antoinet C J Gijsbers1,
  4. Aurore Carré2,
  5. Maureen Holvoet3,
  6. Arie van Haeringen1,4,
  7. Saskia A J Lesnik Oberstein1,
  8. Akemi Tomoda5,
  9. Hiroyo Mabe6,
  10. Michel Polak7,
  11. Koenraad Devriendt3,
  12. Claudia A L Ruivenkamp1,
  13. Emilia K Bijlsma1
  1. 1Center for Human and Clinical Genetics, Leiden University Medical Center (LUMC), Leiden, The Netherlands
  2. 2INSERM U 845, UMR 8200 CNRS, Institut Gustave Roussy, Villejuif, France
  3. 3Center for Human Genetics, University Hospital Leuven and K.U.Leuven, Leuven, Belgium
  4. 4Department of Clinical Genetics, Juliana Children's Hospital/HAGA Teaching Hospital, The Hague, The Netherlands
  5. 5Research Center for Child Mental Development, Graduate School of Medical Sciences, University of Fukui, Fukui, Japan
  6. 6Department of Child Development, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
  7. 7Université Paris Descartes, Sorbonne Paris Cité, INSERM U845, Pediatric endocrinology, AP-HP, Hôpital Necker Enfants Malades, Paris, France
  1. Correspondence to Dr Gijs W E Santen, Center for Human and Clinical Genetics, Leiden University Medical Center (LUMC), Albinusdreef 2, Postbus 9600, Leiden 2300 RC, The Netherlands; santen{at}


Background Deletions including chromosome 14 band q13 have been linked to variable phenotypes. With current molecular methods the authors aim to elucidate a genotype–phenotype correlation by accurately determining the size and location of the deletions and the associated phenotype.

Methods Here the authors report the molecular karyotyping and phenotypic description of seven patients with overlapping deletions including chromosome 14q13.

Results The authors show that deletions including 14q13 result in a recognisable phenotype mainly due to haploinsufficiency of two genes (NKX2-1, PAX9). FOXG1 (on chromosome band 14q12) involvement seems to be the main determinant of phenotype severity. The patients in this study without FOXG1 involvement and deletions of up to 10 Mb have a relatively mild phenotype. The authors cannot explain why some patients in literature with overlapping but smaller deletions appear to have a more severe phenotype. A previously presumed association with holoprosencephaly could not be confirmed as none of the patients in this series had holoprosencephaly.

Conclusions FOXG1 appears the main determinant of the severity of phenotypes resulting from deletions including 14q13. The collected data show no evidence for a locus for holoprosencephaly in the 14q13 region, but a locus for agenesis of the corpus callosum cannot be excluded.

  • Chromosome 14q13
  • NKX2-1
  • PAX9
  • FOXG1
  • holoprosencephaly
  • clinical genetics
  • adrenal disorders
  • pituitary disorders
  • genetics
  • genome-wide
  • molecular genetics
  • thyroid disease
  • endocrinology
  • neurology
  • aneuploidy
  • chromosomal
  • copy number
View Full Text

Statistics from


  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval Most investigations were performed in the course of routine clinical care. In the remaining cases the molecular karyotyping was performed to delineate the exact size and location of a deletion already found by other methods. No new patient samples were required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement All CNV information is present in the paper. No additional data will be uploaded to repositories.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.